Botox for migraine
Chronic migraine can be a debilitating condition, affecting work, relationships and overall quality of life. For patients who experience frequent attacks and don't respond adequately to standard preventive medications, botulinum toxin treatment, commonly known as Botox, can offer significant relief.
Botox is not used for occasional migraines. It’s specifically licensed for chronic migraine, defined as headache occurring on 15 or more days per month, with at least eight of those days meeting migraine criteria. It's important to note that people with suspected medication-overuse for headaches should have this addressed/managed as part of eligibility.
How does Botox work for migraine?
Botox contains botulinum toxin type A, a purified protein that works by blocking the release of certain neurotransmitters involved in pain signalling. When injected into specific muscle areas around the head and neck, it reduces the sensitivity of pain pathways involved in migraine.
It does not simply relax muscles. Its primary effect in migraine is to reduce the transmission of pain signals and dampen the overactive nerve pathways that contribute to chronic attacks.
Who is suitable for treatment?
Botox is typically considered for patients who:
- experience chronic migraine
- have tried at least usually at least three preventive medicines in line with NICE guidelines
- have significant impact on daily functioning
- do not have contraindications to botulinum toxin treatment
A detailed headache history is essential to confirm the diagnosis. Botox is not generally recommended for episodic migraine.
What does the procedure involve?
Treatment follows a standardised injection protocol. Small amounts of Botox are injected into multiple sites across the forehead, temples, back of the head, neck and shoulders.
The procedure:
- takes around 15 to 20 minutes
- is performed in an outpatient setting
- does not require sedation
- involves minimal downtime
Most patients tolerate the injections well, describing brief discomfort at the injection sites.
When will I see results?
Improvement is not immediate. Many patients begin to notice benefit after two to four weeks. The full effect is usually assessed after two treatment cycles.
Injections are repeated every 12 weeks. With ongoing treatment, many patients experience:
- fewer headache days
- reduced severity of attacks
- decreased reliance on acute pain medication
- improved quality of life
Are there side effects?
Botox is generally well tolerated when administered by an experienced clinician. Possible side effects include temporary neck stiffness, mild injection-site discomfort or mild eyelid drooping, which typically resolves.
Serious complications are rare when the procedure is performed correctly.
What happens when its time to review the use of Botox for chronic migraines, and whether to continue?
NICE includes guidelines on stopping treatment when:
- there’s inadequate response after two cycles (commonly defined in TA260 as <30% reduction in headache days), or;
- the person’s migraine becomes episodic again (i.e., below chronic threshold).
These criteria often drive NHS continuation decisions.
How does it fit into overall migraine management?
Botox is one part of a comprehensive migraine strategy. Identifying triggers, optimising sleep, managing stress and reviewing medication use remain important.
For suitable patients with chronic migraine, Botox offers a clinically proven, targeted treatment option that can substantially reduce headache burden and restore daily function. Careful assessment by a headache specialist ensures the treatment is appropriate and safely delivered.